Escitalopram Oxalate Patent Expiration

Escitalopram Oxalate was first introduced by Abbvie Inc in its drug Lexapro on Aug 14, 2002. 22 different companies have introduced drugs containing Escitalopram Oxalate.


Escitalopram Oxalate Patents

Given below is the list of patents protecting Escitalopram Oxalate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lexapro US6916941

(Pediatric)

Crystalline composition containing escitalopram Feb 12, 2023

(Expired)

Abbvie
Lexapro US7420069

(Pediatric)

Crystalline composition containing escitalopram Feb 12, 2023

(Expired)

Abbvie
Lexapro US6916941 Crystalline composition containing escitalopram Aug 12, 2022

(Expired)

Abbvie
Lexapro US7420069 Crystalline composition containing escitalopram Aug 12, 2022

(Expired)

Abbvie



Escitalopram Oxalate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Escitalopram Oxalate Generic API Manufacturers

Several generic applications have been filed for Escitalopram Oxalate. The first generic version for Escitalopram Oxalate was by Norvium Bioscience Llc and was approved on Jul 31, 2007. And the latest generic version is by Ascent Pharmaceuticals Inc and was approved on Jul 15, 2025.

Given below is the list of companies who have filed for Escitalopram Oxalate generic, along with the locations of their manufacturing plants worldwide.